Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Case Report

Unexpected Patch Test Complication in a Professional Ice Hockey Player

Magnus Bruze1, Tomas Eriksson1, Marléne Isaksson1* and Yelverton Tegner2

1Department of Occupational and Environmental Dermatology, Skåne University Hospital, Lund University, Malmö, Sweden

2Yelverton Tegner, Division of Medical Sciences, Department of Health Sciences, Luleå University of Technology, Luleå, Sweden

*Corresponding Author:
Isaksson M
Department of Occupational and Environmental Dermatology
Jan Waldentröms gata 16, level 5, Skåne University Hospital
SE 205 02 Malmö, Sweden
Tel: +46 40 337859
E-mail: marlene.isaksson@med.lu.se

Received date: February 15, 2016; Accepted date: February 26, 2016; Published date: February 29, 2016

Citation: Bruze M, Eriksson T, Isaksson M,Tegner Y (2016) Unexpected Patch Test Complication in a Professional Ice Hockey Player . Occup Med Health Aff 4:229. doi: 10.4172/2329-6879.1000229

Copyright: © 2016 Isaksson M, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Abstract

In a survey on work-related skin problems in professional ice hockey players one player developed a severe patch test reaction with an unexpected complication. The positive reaction to diethyl thiourea was vesiculo-bullous, oedematous and significantly elevated and a spreading several centimeters outside the test area was noted. Starting less than 24h after the patch test application, itching erythematous, multiforme-like lesions appeared on the extremities. The lesions were interpreted as a manifestation of a systemic allergic contact dermatitis secondary to the patch tested allergen. As systemic corticosteroids are considered as doping, we had to treat him with topical clobetasol propionate. Systemic allergic contact dermatitis seems to be an extremely rare complication after patch testing. It has been reported after testing with some textile disperses dyes but not after testing with diethyl thiourea and is not described as a complication in major textbooks.

Keywords

Top